JORVEZA Trademark

Trademark Overview

On Tuesday, June 13, 2017, a trademark application was filed for JORVEZA with the United States Patent and Trademark Office. The USPTO has given the JORVEZA trademark a serial number of 79213908. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Friday, March 7, 2025. This trademark is owned by Dr. Falk Pharma GmbH. The JORVEZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract
jorveza

General Information

Serial Number79213908
Word MarkJORVEZA
Filing DateTuesday, June 13, 2017
Status706 - SECTION 71 ACCEPTED
Status DateFriday, March 7, 2025
Registration Number5398764
Registration DateTuesday, February 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of inflammation of the upper gastrointestinal tract

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 11, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDr. Falk Pharma GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFreiburg 79108
DE
Party NameDr. Falk Pharma GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameDr. Falk Pharma GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, August 10, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 15, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, September 12, 2017ASSIGNED TO EXAMINER
Saturday, September 16, 2017NON-FINAL ACTION WRITTEN
Sunday, September 17, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 20, 2017REFUSAL PROCESSED BY MPU
Wednesday, September 20, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 7, 2017REFUSAL PROCESSED BY IB
Tuesday, October 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, December 9, 2017NOTIFICATION PROCESSED BY IB
Tuesday, February 13, 2018REGISTERED-PRINCIPAL REGISTER
Friday, May 18, 2018FINAL DISPOSITION PROCESSED
Friday, May 18, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 29, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 24, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 13, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 23, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 23, 2024NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sunday, May 13, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, October 11, 2019NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, February 23, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 31, 2024TEAS SECTION 71 RECEIVED
Friday, March 7, 2025REGISTERED-SEC.71 ACCEPTED
Friday, March 7, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, July 11, 2025NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

jorveza gastrointestinal tract upper inflammation preparations treatment pharmaceutical